Glimerit-MP 2 Tablet ER
Marketer
Dr. Ethix's Product & Services Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimerit-MP 2 Tablet ER
Combiflex-DM 2 Extended-Release tablets combine medications to effectively manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin efficiency, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and duration for Combiflex-DM 2 ER, taking it with food to minimize digestive discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the hypoglycemia risk. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should consult their physician before use. Kidney function tests will be performed before treatment begins. Limit alcohol consumption as it may amplify adverse reactions.
Uses of Glimerit-MP 2 Tablet ER
Managing type 2 diabetes
Major Benefits of Glimerit-MP 2 Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimerit-MP 2 Tablet ER with a meal.
Common Side effects of Glimerit-MP 2 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimerit-MP 2 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimerit-MP 2 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. This extended-release medication should be administered with food.
How Glimerit-MP 2 Tablet ER works:
Glimerit-MP 2 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood sugar management when single or dual-agent therapies prove inadequate. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimerit-MP 2 Tablet ER and alcohol is contraindicated due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimerit-MP 2 Tablet ER during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimerit-MP 2 Tablet likely poses a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, possibly causing infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Exercise caution when administering Glimerit-MP 2 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Glimerit-MP 2 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Exercise caution when administering Glimerit-MP 2 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. Glimerit-MP 2 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glimerit-MP 2 Tablet ER :
Should you forget a dose of Glimerit-MP 2 Tablet ER, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimerit-MP 2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes medication |



